Taking people in United StatesNo phase
Records outcomes of people with brain tumors treated with GammaTile radiation
Follows people with brain tumors treated with GammaTile radiation placed during surgery.
Key facts
- Who runs it
- GT Medical Technologies, Inc.
- Where
- Albany, Allentown, Atlanta, Boise, Boston, Carmel, Castro Valley, Chapel Hill, Chattanooga, Cincinnati, Clearwater, Dallas, Denver, Detroit, Englewood, Fairfax, Greenville, Hershey, Houston, Indianapolis, Jacksonville, Kansas City, Kettering, La Jolla, Laguna Hills, Little Rock, Louisville, Miami, Minneapolis, New York, Omaha, Orlando, Palm Springs, Phoenix, Pittsburgh, Providence, San Antonio, San Francisco, Seattle, Shreveport, Syracuse, Tampa, The Bronx, The Woodlands, Valhalla, Weston, and Wilmington, United StatesSee the 53 sites
- Trial code
- Registry title
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Status
- Recruiting
- People taking part
- 600 people, planned
- Started
- 11 Sept 2020
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Treatments tested
- GammaTile
- Record updated
- 22 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a brain tumor who have surgery to remove as much of the tumor as is safe and get GammaTile radiation implants during the same operation.
- Sex
- All sexes can join.
- Disease stage
- Tumors inside the skull (intracranial), removed by maximum safe surgery.
- Earlier treatment
- Must have surgery to remove the tumor and GammaTile implants.
Main reasons for not taking part
- Cannot have brain scans before and after the operation
- Serious medical or mental illness that the investigator thinks would stop treatment or follow-up
- Cannot understand the study or give consent, unless a legal representative consents
- History of poor cooperation or not following medical treatment
- Difficulty returning for follow-up care
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles
- Willing and able to provide informed consent and to participate in all evaluations
Who cannot take part
- Inability to undergo pre-operative and post-operative imaging for disease and implant assessment
- Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups
- Subjects who, in the investigator's opinion, are unable to understand the protocol or to give informed consent, have a history of poor cooperation, noncompliance with medical treatment, or difficulty in returning for follow up care. A legally authorized representative may provide consent if the potential subject lacks the capacity to provide consent themselves
Where in United States
- Albany Medical CenterAlbany, United StatesContact: Tuba AhmedTaking people
- St Luke's University Health, Sacred Heart CampusAllentown, United StatesContact: William Smith, MDTaking people
- Piedmont HealthcareAtlanta, United StatesContact: Adam Nowlan, MDTaking people
- Winship Cancer Institute of Emory UniversityAtlanta, United StatesContact: Kimberly BojanowskiTaking people
- St. Alphonsus Regional Medical CenterBoise, United StatesContact: Ondrej ChoutkaTaking people
- Beth Israel Deaconess Medical CenterBoston, United StatesContact: Stephen DugganTaking people
- Goodman Campbell Brain and SpineCarmel, United StatesContact: Heather CeroTaking people
- Eden Medical CenterCastro Valley, United StatesContact: Lawrence Dickinson, MDTaking people
- University of North Carolina HealthChapel Hill, United StatesContact: Michael A. Garcia, MD, MSNo longer taking part
- CHI Memorial Hospital, CommonSpiritChattanooga, United StatesContact: Ginger WhismanTaking people
- Mayfield Brain and SpineCincinnati, United StatesContact: Vincent DiNapoli, MDTaking people
- BayCare HealthClearwater, United StatesContact: Devon Haydon, MDTaking people
- UT Southwestern Simmons Cancer CenterDallas, United StatesContact: Toral Patel, MDTaking people
- CenturaDenver, United StatesContact: Angela Bohnen, MDNot yet recruiting
- Henry Ford Health SystemDetroit, United StatesContact: Adam M Robin, MDTaking people
- Clinical Research dep. Davison Place. Englewood HealthEnglewood, United StatesContact: Kevin Yao, MDNot yet recruiting
- Colorado Brain & Spine Institute: Swedish CampusEnglewood, United StatesContact: Vadim Tsvankin, MDTaking people
- INOVA HealthFairfax, United StatesContact: Daniel Kim, MDTaking people
- Vidant Heath - ECU Medical CenterGreenville, United StatesContact: Stuart Lee, MDTaking people
- Penn State HealthHershey, United StatesContact: Rachel HorstmanTaking people
- Baylor St. Luke's Medical Center | Baylor College of MedicineHouston, United StatesContact: Akash Patel, MDTaking people
- Houston Methodist HospitalHouston, United StatesContact: David Baskin, MDTaking people
- Indiana University, IU Health Methodist HospitalIndianapolis, United StatesContact: Mitesh ShahTaking people
- Ascension St. Vincent'sJacksonville, United StatesContact: Amanda LindewoodTaking people
- KUMC Dept of NeurosurgeryKansas City, United StatesContact: Kushal ShahTaking people
- Kettering HealthKettering, United StatesContact: Mark Hoeprich, MDTaking people
- UCSD Moores Cancer CenterLa Jolla, United StatesContact: David Piccioni, MD, PhDTaking people
- MemorialCare Health SystemLaguna Hills, United StatesContact: Linda Chan, MDTaking people
- University of Arkansas Medical CenterLittle Rock, United StatesContact: Analiz Rodriguez, MD, PhDTaking people
- Norton Cancer InstituteLouisville, United StatesContact: Parag Sevak, MDTaking people
- Univeristy of Louisville HealthLouisville, United StatesContact: Akshitkumar Mistry, MDTaking people
- Miami Cancer Institute - Baptist Health South FloridaMiami, United StatesContact: Rupesh Kotecha, MDTaking people
- Abbott-Northwestern HospitalMinneapolis, United StatesContact: John Trusheim, MDTaking people
- University of MinnesotaMinneapolis, United StatesContact: Lindsey Sloan, MD, PhDTaking people
- Mount Sinai HospitalNew York, United StatesContact: Michael A. Garcia, MD, MSNo longer taking part
- University of NebraskaOmaha, United StatesContact: Michele Aizenberg, MDTaking people
- Advent Health OrlandoOrlando, United StatesContact: Imran Mohiuddin, MDTaking people
- Orlando HealthOrlando, United StatesContact: Catherine Mercado, MDTaking people
- Desert Regional Medical CenterPalm Springs, United StatesContact: Amir Lavaf, MDTaking people
- HonorHeath Scottsdale Osborn Medical CenterPhoenix, United StatesContact: John Wanebo, MDTaking people
- Allegheny Health NetworkPittsburgh, United StatesContact: Sarah KimutisTaking people
- Brown University HealthProvidence, United StatesContact: Clarck Chen, MD, PhDTaking people
- University of Texas Health Science Center of San AntonioSan Antonio, United StatesContact: John Floyd, MDTaking people
- California Pacific Medical Center, Sutter healthSan Francisco, United StatesContact: Lewis Leng, MDTaking people
- Virginia MasonSeattle, United StatesContact: Huong Pham, MDTaking people
- Willis-Knighton Medical CenterShreveport, United StatesContact: Michael A. Garcia, MD, MSNo longer taking part
- SUNY Upstate Medical CenterSyracuse, United StatesContact: Harish Babu, MDTaking people
- Florida Health Sciences Center, Inc. d/b/a Tampa General HospitalTampa, United StatesContact: Tulika Ranjan, MDTaking people
- Montefiore EinsteinThe Bronx, United StatesContact: Genesis LirianoTaking people
- Texas Oncology-The WoodlandsThe Woodlands, United StatesContact: James Zhu, M.D., Ph.D.Taking people
- Westchester Medical CenterValhalla, United StatesContact: Simon HanftTaking people
- Cleveland Clinic Florida- WestonWeston, United StatesContact: Surabhi Ranjan, MD, FACPTaking people
- Atlantic Brain & SpineWilmington, United StatesContact: Bridgette SmithTaking people
About the trial
What the trial wants to find out
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
The group in the trial
- GammaTile
Patients who have received permanent implants of GammaTile radiation therapy immediately following brain tumor resection.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
- Plain-language title
- Records outcomes of people with brain tumors treated with GammaTile radiationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 22 July 2026